Chertow, G. M., Chang, A. M., Felker, G. M., Heise, M., Velkoska, E., Fellström, B., … Wolf, M. (2024). Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nat Med, 30(8), 2373. https://doi.org/10.1038/s41591-024-03156-7

Chertow, Glenn M., Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M. Charytan, et al. “Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.” Nat Med 30, no. 8 (August 2024): 2373. https://doi.org/10.1038/s41591-024-03156-7.

Chertow GM, Chang AM, Felker GM, Heise M, Velkoska E, Fellström B, et al. Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nat Med. 2024 Aug;30(8):2373.

Chertow, Glenn M., et al. “Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.” Nat Med, vol. 30, no. 8, Aug. 2024, p. 2373. Pubmed, doi:10.1038/s41591-024-03156-7.

Chertow GM, Chang AM, Felker GM, Heise M, Velkoska E, Fellström B, Charytan DM, Clementi R, Gibson CM, Goodman SG, Jardine M, Levin A, Lokhnygina Y, Mears J, Mehran R, Stenvinkel P, Wang AY-M, Wheeler DC, Zoccali C, Ridker PM, Mahaffey KW, Tricoci P, Wolf M. Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nat Med. 2024 Aug;30(8):2373.